Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan.

Source:http://linkedlifedata.com/resource/pubmed/id/16005008

Download in:

View as

General Info

PMID
16005008